Kidney-Related Outcome in Cardiorenal Syndrome Type 3

Link to article at PubMed

Int J Nephrol. 2022 Feb 7;2022:4895434. doi: 10.1155/2022/4895434. eCollection 2022.

ABSTRACT

METHODS: A single-center, retrospective and observational trial. All subjects with positive AKI alert, treated at the University Hospital Brandenburg between January and December 2019, were evaluated. Definition of CRS type 3 was according to predefined criteria. The three endpoint categories were in-hospital death, dialysis, and recovery of kidney function.

RESULTS: . A total number of 1,334 AKI alerts were screened. Finally, 95 subjects received the diagnosis CRS type 3. The survival rates were 47.1% (females) and 43.6% (males). 46.8% of affected females and 33.3% of the males required dialysis therapy. Complete recovery at the time of discharge occurred in 35.8%, and no recovery at all was found in 54.7%.

CONCLUSIONS: . All three predefined study endpoints, the mortality, the prevalence of dialysis, and the percentage of subjects without recovery of kidney function, were notably high. Therefore, AKI patients with imminent or established cardiac complications require the highest attention of nephrologists in charge.

PMID:35178254 | PMC:PMC8844349 | DOI:10.1155/2022/4895434

Leave a Reply

Your email address will not be published.